2Priori S, Bloise R, Crotti L. The long QT syndrome [ J]. Europace, 2001, 3:16-27.
3Zhou Z, Gong Q, Epstein ML, et al. HERG channel dysfunction in human long QT syndrome [ J ]. J Biol Chem , 1998,273:21061-21066.
4Abriel H, Dagmar I. Molecular and clinical determinants of drug-induced long QT syndromants: an iatrogentic channelopathy[J]. Swiss Med Wldy ,2004, 134 : 685-694.
5Towbin JA, Friedman RA. Prolongation of the long QT syndrome and Sudden Infant Death syndrome [ J ]. N Engl J Med, 1998 ,238 : 1760-1761.
6Patmore L, Fraser, S. Effects of sparfloxacin, grepatloxacin, moxifloxacin, andciprofloxacin on cardiac action potential duration[ J ]. Euro J Pharmacol, 2000, 406:449-452.
